We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

EndoChoice

Manufactures platform technologies including endoscopic imaging systems, devices and infection control products and p... read more Featured Products: More products

Download Mobile App




Full Spectrum Endoscopy Detects Significantly More Polyps

By HospiMedica International staff writers
Posted on 31 Mar 2014
A pivotal comparison study shows that full spectrum endoscopy dramatically outperforms standard forward-viewing colonoscopy (SFV).

Researchers at the Rambam Health Care Campus (Haifa, Israel) conducted an international randomized trial in Israel, the Netherlands, and the USA involving 185 participants (18–70 years of age) referred for colorectal cancer screening, polyp surveillance, or diagnostic assessment. More...
The patients underwent same-day, back-to-back tandem colonoscopy; 48% were randomly assigned to receive SFV first, and 52% to receive full-spectrum colonoscopy with the EndoChoice Fuse System colonoscope first. The primary endpoint was adenoma miss rates.

The results showed that by per-lesion analysis, the adenoma miss rate was significantly lower in patients in the full-spectrum endoscopy group (7%) than in those in the SFV procedure group (41%). Full-spectrum endoscopy missed 5 adenomas in 5 patients in whom an adenoma had already been detected with first-pass SFV; none of these missed adenomas that were advanced. SFV, on the other hand, missed 20 adenomas in 15 patients; of those, 3 were advanced adenomas. Five minor adverse events were reported including vomiting, diarrhoea, cystitis, gastroenteritis, and bleeding. The study was published in the March 2014 issue of the Lancet Oncology.

“As the gold standard for colorectal cancer screening, standard forward-viewing colonoscopy still misses a significant percentage of precancerous polyps due to inadequate visualization of the many folds and bends of the colon,” said lead author Ian Gralnek, MD, of the Rambam department of gastroenterology. “These study results confirm that Fuse is an important technological advancement in colorectal cancer screening that significantly improves visualization and has the potential to improve screening outcomes for many patients.”

“The results of this study support our greatest priority as physicians, which is to miss fewer precancerous polyps and improve the quality of our colonoscopies,” added Dr. Gralnek. “It is important for doctors and their patients to know the Fuse endoscopy platform is now available and has the ability to significantly increase adenoma detection rates.”

For the study the researchers used the EndoChoice (Atlanta, GA, USA) Fuse system, which uses three small cameras at the tip of a flexible gastrointestinal endoscope. By using three cameras, the system allows physicians to see nearly twice as much surface area as they can with traditional endoscopes, since the wider angles allow examination of folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional one-camera endoscopes.

Related Links:

Rambam Health Care Campus
EndoChoice



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Lateral Lumbar Interbody Spacer
CALIBER-L
New
Instrument Cabinet
TRZY-068
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.